Patients who developed CRS had correspondingly higher levels of IL-6 and the chemokine IP-10 when measured at week one after infusion (P < .05, Fig 3C), with the single patient experiencing grade 4 CRS (patient 7) demonstrating the highest levels of both. The gene discussed is IL6; the disease is congenital rubella syndrome.